Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health.

Oct 7, 2024 · Novavax vaccine finder provides the most timely and updated information on the locations where our vaccine is available this season.

Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases.

The Novavax COVID-19 Vaccine, Adjuvanted is a vaccine for use in individuals 12 years of age and older to prevent COVID-19. The FDA has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted under an EUA.

Find information for healthcare professionals on the Novavax non-mRNA protein‐based vaccine, including important safety information and efficacy studies.

Sep 10, 2024 · Novavax is a protein subunit vaccine and is based on a more traditional vaccination approach than mRNA vaccines. It contains a lab-made version of the SARS-CoV-2 spike protein which mimics the molecular structure of …

Oct 16, 2023 · In early October the U.S. Food and Drug Administration authorized a new booster shot made by the company Novavax. Like the mRNA-based Pfizer and Moderna shots, it …

May 22, 2025 · Novavax COVID-19 Vaccine: Built on Well-Established Protein Platform Recombinant protein nanoparticle Matrix-M®

May 20, 2025 · The Novavax vaccine is one of three vaccines available in the U.S. for the prevention of COVID-19 and the only one that does not use the relatively new mRNA vaccine technology. Instead, it relies on a traditional virus-blocking …